ASMB
Assembly Biosciences Inc
23.70$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +87.8% | -26.6% | +72.5% | +58.3% | +29.8% | -18.6% | -32.5% | -46.7% | +34.4% | -12.9% | +116.2% | |
| – | +134.0% | -21.6% | +129.8% | +80.7% | +27.1% | -20.6% | -31.3% | -37.1% | +38.0% | -13.7% | +120.4% | |
| – | -6.8% | +5.4% | +187.1% | -49.4% | +12.7% | +27.2% | -23.2% | +14.9% | -62.1% | +93.3% | +52.4% | |
| – | +132.6% | -21.7% | +126.5% | +81.8% | +25.7% | -21.0% | -32.2% | -37.5% | +42.2% | -13.9% | +121.4% | |
| – | – | – | – | +6.9% | +38.8% | -63.5% | -72.7% | +181.0% | -95.4% | +830.2% | +143.5% | |
| – | – | – | – | +0.0% | -100.0% | – | – | +0.0% | -319,700,100.0% | – | – | |
| – | -5.0% | +44.5% | +300.6% | -35.2% | +228.5% | -12.6% | +348.8% | -89.7% | – | – | – | |
| – | -0.8% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | +18.6% | +21.6% | +208.0% | +2.2% | +30.1% | -42.8% | -48.1% | -13.6% | +400.4% | -10.4% | -40.8% | |
| – | +222.8% | +109.3% | +89.5% | +36.9% | +32.3% | 0.0% | -34.2% | +1.4% | +140.7% | +21.9% | +2.0% | |
| – | – | – | – | – | – | +6.8% | -7.4% | +6.8% | -63.7% | -62.2% | +23.4% | |
| – | +50.3% | +73.7% | -10.3% | +73.9% | -53.1% | +165.6% | -42.2% | -6.2% | -81.5% | +26.9% | +100.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +102.7% | -32.7% | +41.6% | +86.2% | +29.7% | -11.9% | -29.8% | -51.1% | -50.3% | -18.8% | +519.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +124.4% | +9.7% | +3.0% | +28.5% | +53.8% | +13.1% | -9.1% | +11.9% | +13.5% | +31.2% | +86.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.